InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,344.16
(
0.47%
)
US TECH 100
18,024.00
(
0.56%
)
Dow Jones
39,497.54
(
0.13%
)
Brent Oil
79.49
(
0.00%
)
Bitcoin
60,350.84
(
-0.87%
)

Replies to post #106111 on Anavex Life Sciences Corp (AVXL)

Replies to #106111 on Anavex Life Sciences Corp (AVXL)
icon url

Jonjones325

05/24/17 3:37 PM

#106114 RE: falconer66a #106111

Thank you
icon url

frrol

05/24/17 4:59 PM

#106120 RE: falconer66a #106111

I think a (lesser) concern is tolerance, not tolerability. That is: would such an S1 agonist's effectiveness attenuate over time. But I haven't seen any tolerance issues arising in S1 research.